focuses his time at Thermo Fisher Scientific on partnering with external innovators in academia and industry in order to bring novel advances to the market. He is excited by opportunities to discuss with colleagues, insights gleaned over fifteen years of tech- transfer experience across academia and industry, and willingly dedicates his time for mentoring junior colleagues. Having trained as a research immunologist, he is fascinated by the tremendous potential of public impact research in improving lives and transforming society, and is humbled by the many opportunities he gets to be a cog in the research innovation wheel.
Tari Suprapto, PhD, RTTP,
is a seasoned technology commercialization professional in the life sciences. She is currently a Senior Advisor for External Innovation with Elanco, a Top 5 global animal health company, and spent over 15 years in the non-profit sector promoting and commercializing innovative opportunities from world class research institutions such as the Salk Institute, The Rockefeller University, and Memorial Sloan-Kettering Cancer Center. Tari has extensive experience in licensing, building and managing strategic alliances with industry and other academic institutions, and a well-rounded technical background in a variety of therapeutic areas resulting from her PhD in Molecular & Cellular Biology from The Rockefeller University and an Honors BA from Swarthmore College.
Cathy J Tralau-Stewart PhD, FRSC,
is Senior Director of Strategic Academic Alliances, Center for External Innovation, Takeda. She is an experienced drug discovery pharmacologist who has spent the last 14 years developing inter-disciplinary drug & technology discovery teams in the academic-industry interface. She started her career at GSK and then moved to Imperial College London and University of California San Francisco leading therapeutics and medtech, translation and commercialization initiatives (Imperial College London DDC and UCSF Catalyst). She has a proven track record, in both industry and academia, for delivering many development candidates and small molecule and biological drugs to patients.
is the Associate Director of Licensing at the USC Stevens Center for Innovation. At USC, he manages a team of four licensing associates and is responsible for the management and licensing of the life sciences portfolio. He has over 18 years of experience in academic and industry technology transfer. Prior to coming to USC in 2017, he served as Associate Director of Licensing at the Scripps Research Institute, where he negotiated over 100 license agreements and managed a portfolio of over 200 technologies. His industry experience includes four years at Stratagene selling research reagent consumables and instruments. He specializes in the evaluation, protection, marketing, and licensing of inventions in a wide variety of life science-related fields, including chemistry, oncology, gene therapy, biology, and immunology. He also has extensive experience in start-up formation and corporate sponsored research agreements.